Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rusalatide acetate by Chrysalis BioTherapeutics for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome): Likelihood of Approval
Rusalatide acetate is under clinical development by Chrysalis BioTherapeutics and currently in Phase II for Radiation Toxicity (Radiation Sickness, Acute...